Kindlin 2– β-catenin complex was originally confirmed in breast cancer cells, in which Kindlin 2 was recruited by β-catenin to activate Wnt target gene AXIN2, and, in turn, promote the EMT process [14]. This evidence concerns the gene FERMT2 and breast carcinoma.